Heterogeneity of the resistance to gefitinib treatment in a non‐small cell lung cancer patient with active epidermal growth factor receptor mutation

著者: Xu, Chong‐Rui, Zhong, Wen‐Zhao, Zhou, Qing, Zhang, Xu‐Chao, Yang, Jin‐Ji, Wu, Yi‐Long
出版年 Thorac Cancer (2016)

Principles of biopsy in suspected lung cancer: priority still based on invasion in the era of targeted therapy?

著者: Chen, Hua-Jun, Yang, Jin-Ji, Xu, Chong-Rui, Lei, Yuan-Yuan, Luo, Dong-Lan, Yan, Hong-Hong, Wu, Yi-Long
出版事項 2013

EGFR mutations in early‐stage and advanced‐stage lung adenocarcinoma: Analysis based on large‐scale data from China

著者: Pi, Can, Xu, Chong‐Rui, Zhang, Ming‐feng, Peng, Xiao‐xiao, Wei, Xue‐wu, Gao, Xing, Yan, Hong‐Hong, Zhou, Qing
出版年 Thorac Cancer (2018)

Feasibility of computed tomography-guided core needle biopsy in producing state-of-the-art clinical management in Chinese lung cancer

著者: Chen, Hua-Jun, Yang, Jin-Ji, Fang, Liang-Yi, Huang, Min-Min, Yan, Hong-Hong, Zhang, Xu-Chao, Xu, Chong-Rui, Wu, Yi-Long
出版年 Thorac Cancer (2014)

Nedaplatin/Gemcitabine Versus Carboplatin/Gemcitabine in Treatment of Advanced Non-small Cell Lung Cancer: A Randomized Clinical Trial

著者: Yang, Jin-ji, Zhou, Qing, Liao, Ri-qiang, Huang, Yi-sheng, Xu, Chong-rui, Wang, Zhen, Wang, Bin-chao, Chen, Hua-jun, Wu, Yi-long
出版事項 2012

Familial association of lung cancer with liver cancer in first-degree relatives

著者: Xu, Chong-Rui, Lin, Huan, Su, Jian, Zhang, Xu-Chao, Huang, Yi-Sheng, Yang, Xue-Ning, Zhou, Qing, Yang, Jin-Ji, Zhong, Wen-Zhao, Wu, Yi-Long
出版年 Cancer Manag Res (2019)

Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-L...

著者: Wu, Yi-Long, Xu, Chong-Rui, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Shi, Jian Hua, Märten, Angela, Fan, Jean, Peil, Barbara, Zhou, Caicun
出版年 Onco Targets Ther (2018)

Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

著者: Zhou, Qing, Yang, Jin-Ji, Chen, Zhi-Hong, Zhang, Xu-Chao, Yan, Hong-Hong, Xu, Chong-Rui, Su, Jian, Chen, Hua-Jun, Tu, Hai-Yan, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
出版年 J Hematol Oncol (2016)

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

著者: Dong, Zhong-Yi, Zhang, Jia-Tao, Liu, Si-Yang, Su, Jian, Zhang, Chao, Xie, Zhi, Zhou, Qing, Tu, Hai-Yan, Xu, Chong-Rui, Yan, Li-Xu, Li, Yu-Fa, Zhong, Wen-Zhao, Wu, Yi-Long
出版年 Oncoimmunology (2017)

Lung Cancer Treatment Disparities in China: A Question in Need of an Answer

著者: Yang, Lu-Lu, Zhang, Xu-Chao, Yang, Xue-Ning, Yang, Jin-Ji, Wang, Zhen, Chen, Hua-Jun, Yan, Hong-Hong, Xu, Chong-Rui, Guan, Ji-Lin, He, Yan-Yan, Zhong, Wen-Zhao, An, She-Juan, Wu, Yi-Long
出版事項 2014

Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study

著者: Dong, Song, Zhao, Ning, Deng, Wei, Sun, Hui-wen, Niu, Fei-yu, Yang, Jin-ji, Zhong, Wen-zhao, Li, Feng, Yan, Hong-hong, Xu, Chong-rui, Zhang, Qiu-yi, Yang, Xue-ning, Liao, Ri-qiang, Nie, Qiang, Wu, Yi-long
出版年 World J Surg Oncol (2017)

The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer

著者: Gou, Lan-Ying, Li, An-Na, Yang, Jin-Ji, Zhang, Xu-Chao, Su, Jian, Yan, Hong-Hong, Xie, Zhi, Lou, Na-Na, Liu, Si-Yang, Dong, Zhong-Yi, Gao, Hong-Fei, Zhou, Qing, Zhong, Wen-Zhao, Xu, Chong-Rui, Wu, Yi-Long
出版年 Oncotarget (2016)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma

著者: Sun, Hao, Liu, Si-Yang, Zhou, Jia-Ying, Xu, Jin-Tian, Zhang, Huang-Kai, Yan, Hong-Hong, Huan, Jiao-Jiao, Dai, Ping-Ping, Xu, Chong-Rui, Su, Jian, Guan, Yan-Fang, Yi, Xin, Yu, Rong-Shan, Zhong, Wen-Zhao, Wu, Yi-Long
出版年 EBioMedicine (2020)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer

著者: Kang, Jin, Zhang, Xu-Chao, Chen, Hua-Jun, Zhong, Wen-Zhao, Xu, Yang, Su, Jian, Zhou, Qing, Tu, Hai-Yan, Wang, Zhen, Xu, Chong-Rui, Yang, Xue-Ning, Chen, Zhi-Hong, Wu, Xue, Zhang, Xian, Shao, Yang, Wu, Yi-Long, Yang, Jin-Ji
出版年 Front Oncol (2020)

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations

著者: Lou, Na-Na, Zhang, Xu-Chao, Chen, Hua-Jun, Zhou, Qing, Yan, Li-Xu, Xie, Zhi, Su, Jian, Chen, Zhi-Hong, Tu, Hai-Yan, Yan, Hong-Hong, Wang, Zhen, Xu, Chong-Rui, Jiang, Ben-Yuan, Wang, Bin-Chao, Bai, Xiao-Yan, Zhong, Wen-Zhao, Wu, Yi-Long, Yang, Jin-Ji
出版年 Oncotarget (2016)

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I...

著者: Zhang, Yi-Chen, Chen, Zhi-Hong, Zhang, Xu-Chao, Xu, Chong-Rui, Yan, Hong-Hong, Xie, Zhi, Chuai, Shao-Kun, Ye, Jun-Yi, Han-Zhang, Han, Zhang, Zhou, Bai, Xiao-Yan, Su, Jian, Gan, Bin, Yang, Jin-Ji, Li, Wen-Feng, Tang, Wei, Luo, Feng Roger, Xu, Xiao, Wu, Yi-Long, Zhou, Qing
出版年 EBioMedicine (2019)